BioLife Solutions, Inc.
- BLFS
- NASDAQ
- Medical - Instruments & Supplies
- Cell & Gene Therapy Bioproduction
- Biopreservation/Cryopreservation
$38.61
Quote Oct 5, 2026, 08:00 PM UTC
+9.53%over the last month
Max drawdown −6.2%From 1-month high −1.6%3 months +42.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$1.89B
Quote Oct 5
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$31.00
−19.7% from here
Floor
$37.92
1.8% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BLFSPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q3 2025 revenue $28.1M
- Product$26.3M93.5%
- Rental Revenue$1.8M6.4%
Industry
Medical - Instruments & Supplies
Employees
155